We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 241 results
  1. Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure

    Background

    Wilson’s disease is a genetic disorder inherited in a recessive manner, caused by mutations in the copper-transporter ATP7B. Although it is...

    Sylwia Szeląg-Pieniek, Stefan Oswald, ... Mateusz Kurzawski in Pharmacological Reports
    Article Open access 11 June 2021
  2. The effect of new atypical antipsychotic drugs on the expression of transcription factors regulating cytochrome P450 enzymes in rat liver

    Background

    Our recent studies showed that prolonged administration of novel atypical antipsychotics affected the expression and activity of cytochrome...

    Przemysław J. Danek, Władysława A. Daniel in Pharmacological Reports
    Article Open access 15 June 2024
  3. The reference liver—CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype

    Background

    Hepatic enzymes involved in drug metabolism vary markedly in expression, abundance and activity, which affects individual susceptibility to...

    Mateusz Kurzawski, Sylwia Szeląg-Pieniek, ... Marek Droździk in Pharmacological Reports
    Article Open access 06 November 2021
  4. Co-administration of Acarbose with Aqueous Extract of Root and Leaf of Sphenocentrum jollyanum Accelerates Wound Closure in Type 2 Diabetic Rats

    Acarbose is an anti-hyperglycemic drug recognized as an inhibitor of carbohydrate-metabolizing enzymes. Hyperglycemia is a risk factor for wound...

    Oluwakemi Adeleke, Stephen Adefegha, Ganiyu Oboh in Revista Brasileira de Farmacognosia
    Article 31 October 2023
  5. Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes

    Synthetic cannabinoids, a new class of psychoactive substances, are potent agonists of cannabinoid receptors, which mimic the psychoactive effects of...

    Tae Yeon Kong, Ju-Hyun Kim, ... Hye Suk Lee in Archives of Pharmacal Research
    Article 23 July 2018
  6. GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders

    Movement disorders are neurological conditions characterized by involuntary motor movements, such as dystonia, ataxia, chorea myoclonus, tremors,...

    Divya Soni, Puneet Kumar in Pharmacological Reports
    Article 26 July 2022
  7. Effects of simvastatin on nuclear receptors, drug metabolizing enzymes and transporters expression in Human Umbilical Vein Endothelial Cells

    Background

    Vascular endothelial cells (EC) are constantly exposed to endo- and exogenous compounds, which may disturb EC function. One of the...

    Joanna Łapczuk-Romańska, Anna Wajda, ... Marek Droździk in Pharmacological Reports
    Article 23 March 2018
  8. Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review

    Cannabinoid receptors, endogenous cannabinoids (endocannabinoids), and the enzymes involved in the biosynthesis and degradation of the...

    Gidion Wilson, Lingling Yang, ... Xueqin Ma in Pharmacological Reports
    Article 31 October 2023
  9. Investigation of the Anti-asthmatic Activity of Solidagenone, In Vitro Toxicity Versus In Silico Studies

    Solidagenone, a labdane diterpene isolated from inflorescences of Solidago chilensis Meyen, Asteraceae, was investigated for its anti-inflammatory...

    Deise Cristina Drummond Xavier Paes Lopes, Thais Morais de Brito, ... Eduardo Ricci Junior in Revista Brasileira de Farmacognosia
    Article 15 November 2023
  10. Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients

    Candesartan cilexetil is an angiotensin II receptor blocker and it is widely used to treat hypertension and heart failure. This drug is a prodrug...

    Eui Hyun Jung, Chang-Keun Cho, ... Seok-Yong Lee in Archives of Pharmacal Research
    Article 24 November 2021
  11. Tetrachloromethane Induced Acute Liver Injury in Mice: Biochemical and Histopathological Study of the Hepatoprotective Effect of Hep-X Standardized Botanical Dietary Supplement

    This work was aimed at investigating the hepatoprotective effect of Hep-X, a polyherbal formulation containing Silybum marianum L. (Milk thistle), Rosm...

    Cinel Koksal Karayildirim, Adem Guner, ... Altug Yavasoglu in Pharmaceutical Chemistry Journal
    Article 20 March 2023
  12. Cannabinoids in the treatment of glioblastoma

    Glioblastoma (GBM) is the most prevalent primary malignant tumor of the nervous system. While the treatment of other neoplasms is increasingly more...

    Barbara Buchalska, Katarzyna Kamińska, ... Agnieszka Cudnoch-Jędrzejewska in Pharmacological Reports
    Article 08 March 2024
  13. Ginsenoside Rg5 as an anticancer drug: a comprehensive review on mechanisms, structure–activity relationship, and prospects for clinical advancement

    Cancer remains one of the leading causes of death in the world. Despite the considerable success of conventional treatment strategies, the incidence...

    Tilal Elsaman, Ali Mahmoud Muddathir, ... Javad Sharifi-Rad in Pharmacological Reports
    Article 25 March 2024
  14. Pharmacogenomics and Cancer Treatment

    Somatic and germline genetic variations are two types of interindividual variations affecting drug response in cancer treatment. Pharmacogenomics...
    Reference work entry 2023
  15. Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems

    Sulforaphane is an isothiocyanate compound that has been derived from cruciferous vegetables. It was shown in numerous studies to be active against...

    Mohammad M. Kamal, Sharmin Akter, ... Sami Nazzal in Archives of Pharmacal Research
    Article 10 March 2020
  16. Cis-element architecture of Nrf2–sMaf heterodimer binding sites and its relation to diseases

    Cellular detoxication is essential for health because it provides protection against various chemicals and xenobiotics. The KEAP1–NRF2 system is...

    Akihito Otsuki, Masayuki Yamamoto in Archives of Pharmacal Research
    Article 02 December 2019
  17. Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists

    Over the last decade, new psychoactive substances (NPS) have continuously been the focus of the international society since their emergence on the...

    Eun Yong Chung, Hye ** Cha, ... Jaesuk Yun in Archives of Pharmacal Research
    Article 02 April 2021
  18. Disease Prevention and Treatment Using β-Carotene: the Ultimate Provitamin A

    Humans being unable to synthesize beta-carotene, the provitamin A, depend on external sources as its supplement. Health benefits and dietary...

    Raksha Anand, Lalit Mohan, Navneeta Bharadvaja in Revista Brasileira de Farmacognosia
    Article 30 May 2022
  19. Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction

    Pooled evidence conveys the association between polyunsaturated fatty acids and infectious disease. SARS-CoV-2, an enveloped mRNA virus, was also...

    Prodip Kumar Baral, Mohammad Tohidul Amin, ... Mohammad Salim Hossain in Revista Brasileira de Farmacognosia
    Article 02 December 2021
  20. Hyperoside attenuates pyrrolizidine alkaloids-induced liver injury by ameliorating TFEB-mediated mitochondrial dysfunction

    Pyrrolizidine alkaloids (PAs) are potent hepatotoxins that can cause liver damage. Hyperoside (Hyp), a natural flavonoid, can be extracted from...

    Jie Xu, Aizhen **ong, ... Li Yang in Archives of Pharmacal Research
    Article 01 August 2023
Did you find what you were looking for? Share feedback.